Author:
Malaina Iker,Martinez Luis,Salcines-Cuevas David,Teran-Navarro Hector,Ocejo-Vinyals J. Gonzalo,Gonzalez-Lopez Elena,Soriano Vicente,Ubeda María,Perez Pinilla Martin-Blas,Martinez de la Fuente Ildefonso,Alvarez-Dominguez Carmen
Abstract
AbstractThis paper presents a new procedure for vaccine design against highly variable viruses such as Hepatitis C. The procedure uses an optimization algorithm to design vaccines that maximize the coverage of epitopes across different virus variants. Weighted epitopes based on the success ratio of immunological assays are used to prioritize the selection of epitopes for vaccine design. The procedure was successfully applied to design DC vaccines loaded with two HCV peptides, STG and DYP, which were shown to be safe, immunogenic, and able to induce significant levels of anti-viral cytokines, peptide-specific cellular immune responses and IgG antibodies. The procedure could potentially be applied to other highly variable viruses that currently lack effective vaccines.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. World Health Organization. Fact sheet on Hepatitis C. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed on 02/23/2023.
2. Chaudhari, R., Fouda, S., Sainu, A. & Pappachan, J. M. Metabolic complications of hepatitis C virus infection. World J. Gastroenterol. 27(13), 1267–1282. https://doi.org/10.3748/wjg.v27.i13.1267.PMID:33833481;PMCID:PMC8015302.) (2021).
3. European Centre for Disease Prevention and Control. Hepatitis C. In: ECDC. Annual epidemiological report for 2020. Stockholm: ECDC; 2022.
4. Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Epidemiological surveillance of hepatitis C in Spain, 2020.
5. Soriano, V. et al. Ultra-long-acting (XLA) antivirals for chronic viral hepatitis. Int. J. Infect. Dis. 114, 45–50 (2022).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献